Radiofrequency ablation versus stereotactic body radiotherapy for recurrent hepatocellular carcinoma: a multicenter, propensity score matching analysis
SBRT appears to be an effective priority to RFA for RHCC patients especially when RFA is not feasible due to tumor location, size, and proximity to major vessels.
Authors
- Xiaolu Lin (ORCID: https://orcid.org/0000-0001-9994-1537)
- Mao-Lin Yan (ORCID: https://orcid.org/0000-0002-9852-2661)
- Jinglei Zhang (ORCID: https://orcid.org/0000-0003-1438-6568)
- Jie Shi (ORCID: https://orcid.org/0000-0001-6072-7031)
- Wei-Xing Guo
- Xin Song (ORCID: https://orcid.org/0000-0002-1509-6223)
- Shuqun Cheng (ORCID: https://orcid.org/0000-0002-6098-8028)
- Lei Guo (ORCID: https://orcid.org/0000-0002-5166-5374)
- Yan Meng (ORCID: https://orcid.org/0000-0002-7421-578X)
- Zhuang Ma (ORCID: https://orcid.org/0000-0002-7897-5663)
- Jie Xue
- Feng-Hua Liu
- Chong‐De Lu
Institutions
- Fujian Medical University (CN)
- Xuzhou Medical College (CN)
- Second Military Medical University (CN)
- Eastern Hepatobiliary Surgery Hospital (CN)
- Xuzhou No.1 People's Hospital (CN)
- Fujian Provincial Hospital (CN)
Publication Details
- Journal
- BMC Cancer
- Published
- 2025-03-08
- DOI
- https://doi.org/10.1186/s12885-025-13800-1
- Citations
- 1
- Primary Topic
- Hepatocellular Carcinoma Treatment and Prognosis
- Type
- article
- Field-Weighted Citation Impact
- 1.32